News
Treatment of Patients With Metastatic Renal Carcinoma With a Combination of Subcutaneous Interleukin-2 and Interferon Alfa With or Without Fluorouracil PURPOSE: To provide an estimate of long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback